
AMEX · OGEN
Oragenics, Inc.
Healthcare · Biotechnology
$0.50
Up+$0.01 (+2.54%)
Updated Sep 17, 2026, 8:30 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 3.88M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.48 – $1.11
- Volume
- 54.73K
- Avg. volume
- 130.21K
Price performance
OGEN price history
1M range · 20 trading sessions · Daily adjusted prices
OGEN closed at $0.50 after 20 trading sessions, down 5.70% for the selected period.
- Last close
- $0.50
- Period change
- -5.70%
- Period low
- $0.48
- Period high
- $0.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.50 | $0.5163 | $0.48 | $0.50 | 54.73K |
| Sep 15, 2026 | $0.487 | $0.4988 | $0.4756 | $0.4876 | 25.53K |
| Sep 14, 2026 | $0.484 | $0.499 | $0.4775 | $0.499 | 24.66K |
| Sep 11, 2026 | $0.503 | $0.5036 | $0.478 | $0.478 | 67.02K |
| Sep 10, 2026 | $0.5051 | $0.5053 | $0.5025 | $0.5033 | 9.24K |
| Sep 9, 2026 | $0.52 | $0.52 | $0.5052 | $0.515 | 5.35K |
| Sep 8, 2026 | $0.51 | $0.5223 | $0.51 | $0.5223 | 12.63K |
| Sep 4, 2026 | $0.4992 | $0.52 | $0.4992 | $0.51 | 8.73K |
| Sep 3, 2026 | $0.5061 | $0.5234 | $0.496 | $0.4985 | 22.89K |
| Sep 2, 2026 | $0.508 | $0.5329 | $0.4973 | $0.5061 | 25.81K |
| Sep 1, 2026 | $0.496 | $0.5189 | $0.4958 | $0.499 | 16.25K |
| Aug 31, 2026 | $0.515 | $0.5268 | $0.4901 | $0.5098 | 101.21K |
| Aug 28, 2026 | $0.5289 | $0.533 | $0.523 | $0.5242 | 74.77K |
| Aug 27, 2026 | $0.528 | $0.54 | $0.5124 | $0.532 | 29.84K |
| Aug 26, 2026 | $0.54 | $0.54 | $0.5202 | $0.53 | 7.24K |
| Aug 25, 2026 | $0.505 | $0.528 | $0.505 | $0.5201 | 12.97K |
| Aug 24, 2026 | $0.52 | $0.5298 | $0.511 | $0.5195 | 30.53K |
| Aug 21, 2026 | $0.5312 | $0.5449 | $0.52 | $0.525 | 56.51K |
| Aug 20, 2026 | $0.546 | $0.551 | $0.5302 | $0.54 | 16.3K |
| Aug 19, 2026 | $0.5499 | $0.555 | $0.5302 | $0.5302 | 11.08K |
Latest OGEN news
The latest Smart Investors Daily articles mentioning OGEN.
Stock researchCompany · Financials
Loading stock research…

